Rheumatology Advance Access originally published online on July 19, 2005
Rheumatology 2005 44(9):1196; doi:10.1093/rheumatology/kei009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
LETTER TO THE EDITOR |
RUNX1 intronic SNP is not associated with rheumatoid arthritis susceptibility in Dutch Caucasians
Department of Rheumatology and 1 Section of Molecular Epidemiology, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands
Correspondence to: J. Wesoly, Department of Rheumatology, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands. E-mail: j.z.wesoly@lumc.nl
| The first 10% of the full text of this article appears below. |
SIR, Among a number of genes, RUNX1, a haematopoietic transcription activator and repressor, has been recently identified as a rheumatoid arthritis (RA) susceptibility gene [1]. In order to replicate and confirm this finding, we set out to determine the genotype and allele frequencies of RUNX1 intronic gene variant (rs2268277) in a Caucasian population of RA